Sudheeran Kannoth

About

Dr. Sudheeran Kannoth is a trained autoimmune neurologist. He has done a fellowship in autoimmune neurology from Mayo Clinic, Rochester, MN, USA. This included interpretation and reporting of neuronal antibody tests in the Mayo Clinic's Neuroimmunology laboratory as well as clinical care of the patient in the Mayo Clinic's autoimmune neurology clinic under the Department of Neurology. He has characterized and described the syndrome of autoimmune atypical parkinsonism. He has developed the diagnostic criteria for intracranial infectious (mycotic) aneurysm

Employment

• Amrita Institute of Medical Sciences and Research Centre Associate Professor
  2013 - Present

Education

• Mayo Clinic Fellowship in Autoimmune Neurology
  2010 - 2011
• Sree Chitra Thirunal Institute for Medical Sciences and Technology DM
  2003 - 2005
• Jawaharlal Institute of Post Graduate Medical Education and Research MD
  1999 - 2002
• Government Medical College MBBS
  1991 - 1997

Projects & Funding

Projects & funding information is unavailable.

Publications (28)

• Experience of bortezomib use in refractory autoimmune neurological disorders
  Multiple Sclerosis and Related Disorders 2026 DOI: 10.1016/j.msard.2025.106870
  +Save
• Decoding a cryptic brain
  Neuroimmunology Reports 2025 DOI: 10.1016/j.nerep.2025.100261
  +Save
• Super refractory status epilepticus secondary to autoimmune glial fibrillary acidic protein Astrocytopathy
  Epileptic Disorders 2025 DOI: 10.1002/epd2.70001
  +Save
• Autoimmune Atypical Parkinsonism: A 10 year follow up of the original cohort
  Neurological Sciences 2025 DOI: 10.1007/s10072-025-07995-1
  +Save
• Autoimmune encephalitis with autoimmune myocarditis
  BMJ Case Reports 2025 DOI: 10.1136/bcr-2025-264794
  +Save
• MOG IgG antibody positivity from laboratory to clinical practice: A real world experience
  Multiple Sclerosis and Related Disorders 2025 DOI: 10.1016/j.msard.2024.106249
  +Save
• MOG positive primary autoimmune meningitis mimicking tuberculous meningitis: a case series
  BMJ Neurology Open 2025 DOI: 10.1136/bmjno-2024-000999
  +Save
• Cerebrospinal fluid indices as predictors of treatment response in autoimmune encephalitis
  Multiple Sclerosis and Related Disorders 2023 DOI: 10.1016/j.msard.2023.104996
  +Save
• The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia
  Multiple Sclerosis and Related Disorders 2023 DOI: 10.1016/j.msard.2023.104736
  +Save
• Autoimmune parkinsonism with faciobrachiocrural dystonic seizures: a new phenotype of leucine-rich glioma-inactivated 1 (LGI1) autoimmunity
  Acta Neurologica Belgica 2022 DOI: 10.1007/s13760-022-02018-8
  +Save